This report provides a comprehensive analysis of the global Bifendate Tablets market, focusing on its application in treating liver diseases through the reduction of hepatic damage. The study evaluates market dynamics, including growth drivers and emerging opportunities, across various types and applications such as hospitals and clinics. Covering key regions including the Americas, APAC, and Europe, the research offers detailed forecasts and competitive intelligence on major industry players, product segmentation, and strategic market positioning through 2032.

Market Overview

The global Bifendate Tablets market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate over the forecast period.

Product Profile and Therapeutic Use

Bifendate tablets are utilized in the treatment of liver diseases. The primary ingredient, diphenyl diester, serves as an intermediate in the synthesis of Schisandrin. The therapeutic capabilities of this compound include:

• Reducing liver damage caused by carbon tetrachloride.
• Increasing alanine aminotransferase (ALT).
• Reducing the prednisone-induced increase in hepatic ALT.

Regional Market Analysis

The report provides detailed projections for key regional markets, noting expected growth from 2025 through 2032 at a consistent compound annual growth rate:

• United States: Expected to see market expansion through 2032.
• China: Expected to see market expansion through 2032.
• Europe: Expected to see market expansion through 2032.

Market Segmentation

By Type

• Compound Bifendate Tablets
• Bifendate Tablets

By Application

• Hospital
• Clinic
• Others

By Region

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Key Market Dynamics

The global Bifendate Tablets industry is characterized by a competitive landscape where the two largest companies held a significant portion of the market share in 2025. The report analyzes company formation, revenue, market share, latest developments, and M&A activity.

Leading Companies

The following companies have been profiled based on primary expert input, product portfolio analysis, and market penetration:

• Revised Pharmaceutical Group
• Pyeong Kwang Pharmaceutical Co., Ltd.
• Chifeng Weikang Biochemical Pharmaceutical Co., Ltd.
• Shanghai Jinbu Huan Lankao Pharmaceutical Co., Ltd.
• Jiangsu Pengyao Pharmaceutical Co., Ltd.
• Shanxi Taiyuan Pharmaceutical Co., Ltd.
• Liaoyuan Baikang Pharmaceutical Co., Ltd.
• Liaoning Yaolian Pharmaceutical Co., Ltd.
• Ruiyang Pharmaceutical Co., Ltd.

About the Research Report

Produced by LP Information, Inc. (LPI), the "Bifendate Tablets Industry Forecast" provides a comprehensive analysis of the global landscape. The report reviews total world sales in 2025 and offers a detailed analysis in US$ millions of projected sales for 2026 through 2032, broken down by region, market sector, and sub-sector.

Research Methodology and Scope

Using a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study offers a nuanced view of the current state and future trajectory of the industry. It evaluates key market trends, drivers, and affecting factors, highlighting emerging pockets of opportunity. Furthermore, the report analyzes the strategies of leading global companies, focusing on:

• Bifendate Tablets portfolios and capabilities
• Market entry strategies
• Market positions
• Geographic footprints

Key Questions Addressed

• What is the 10-year outlook for the global Bifendate Tablets market?
• What factors are driving Bifendate Tablets market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Bifendate Tablets market opportunities vary by end market size?
• How does Bifendate Tablets break out by Type and by Application?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Bifendate Tablets Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Bifendate Tablets by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Bifendate Tablets by Country/Region, 2021, 2025 & 2032

  • 2.2 Bifendate Tablets Segment by Type

    • 2.2.1 Compound Bifendate Tablets

    • 2.2.2 Bifendate Tablets

    • 2.2.3 Bifendate Tablets Sales by Type

      • 2.2.3.1 Global Bifendate Tablets Sales Market Share by Type (2021-2026)
      • 2.2.3.2 Global Bifendate Tablets Revenue and Market Share by Type (2021-2026)
      • 2.2.3.3 Global Bifendate Tablets Sale Price by Type (2021-2026)

  • 2.3 Bifendate Tablets Segment by Application

    • 2.3.1 Hospital

    • 2.3.2 Clinic

    • 2.3.3 Others

    • 2.3.4 Bifendate Tablets Sales by Application

      • 2.3.4.1 Global Bifendate Tablets Sale Market Share by Application (2021-2026)
      • 2.3.4.2 Global Bifendate Tablets Revenue and Market Share by Application (2021-2026)
      • 2.3.4.3 Global Bifendate Tablets Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global Bifendate Tablets Breakdown Data by Company

    • 3.1.1 Global Bifendate Tablets Annual Sales by Company (2021-2026)

    • 3.1.2 Global Bifendate Tablets Sales Market Share by Company (2021-2026)

  • 3.2 Global Bifendate Tablets Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Bifendate Tablets Revenue by Company (2021-2026)

    • 3.2.2 Global Bifendate Tablets Revenue Market Share by Company (2021-2026)

  • 3.3 Global Bifendate Tablets Sale Price by Company

  • 3.4 Key Manufacturers Bifendate Tablets Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Bifendate Tablets Product Location Distribution

    • 3.4.2 Players Bifendate Tablets Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Bifendate Tablets by Geographic Region

  • 4.1 World Historic Bifendate Tablets Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Bifendate Tablets Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Bifendate Tablets Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Bifendate Tablets Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Bifendate Tablets Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Bifendate Tablets Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Bifendate Tablets Sales Growth

  • 4.4 APAC Bifendate Tablets Sales Growth

  • 4.5 Europe Bifendate Tablets Sales Growth

  • 4.6 Middle East & Africa Bifendate Tablets Sales Growth

• 5 Americas

  • 5.1 Americas Bifendate Tablets Sales by Country

    • 5.1.1 Americas Bifendate Tablets Sales by Country (2021-2026)

    • 5.1.2 Americas Bifendate Tablets Revenue by Country (2021-2026)

  • 5.2 Americas Bifendate Tablets Sales by Type (2021-2026)

  • 5.3 Americas Bifendate Tablets Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Bifendate Tablets Sales by Region

    • 6.1.1 APAC Bifendate Tablets Sales by Region (2021-2026)

    • 6.1.2 APAC Bifendate Tablets Revenue by Region (2021-2026)

  • 6.2 APAC Bifendate Tablets Sales by Type (2021-2026)

  • 6.3 APAC Bifendate Tablets Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Bifendate Tablets by Country

    • 7.1.1 Europe Bifendate Tablets Sales by Country (2021-2026)

    • 7.1.2 Europe Bifendate Tablets Revenue by Country (2021-2026)

  • 7.2 Europe Bifendate Tablets Sales by Type (2021-2026)

  • 7.3 Europe Bifendate Tablets Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Bifendate Tablets by Country

    • 8.1.1 Middle East & Africa Bifendate Tablets Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Bifendate Tablets Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Bifendate Tablets Sales by Type (2021-2026)

  • 8.3 Middle East & Africa Bifendate Tablets Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Bifendate Tablets

  • 10.3 Manufacturing Process Analysis of Bifendate Tablets

  • 10.4 Industry Chain Structure of Bifendate Tablets

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Bifendate Tablets Distributors

  • 11.3 Bifendate Tablets Customer

• 12 World Forecast Review for Bifendate Tablets by Geographic Region

  • 12.1 Global Bifendate Tablets Market Size Forecast by Region

    • 12.1.1 Global Bifendate Tablets Forecast by Region (2027-2032)

    • 12.1.2 Global Bifendate Tablets Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Bifendate Tablets Forecast by Type (2027-2032)

  • 12.7 Global Bifendate Tablets Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 Revised Pharmaceutical Group

    • 13.1.1 Revised Pharmaceutical Group Company Information

    • 13.1.2 Revised Pharmaceutical Group Bifendate Tablets Product Portfolios and Specifications

    • 13.1.3 Revised Pharmaceutical Group Bifendate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 Revised Pharmaceutical Group Main Business Overview

    • 13.1.5 Revised Pharmaceutical Group Latest Developments

  • 13.2 Pyeong Kwang Pharmaceutical Co., Ltd.

    • 13.2.1 Pyeong Kwang Pharmaceutical Co., Ltd. Company Information

    • 13.2.2 Pyeong Kwang Pharmaceutical Co., Ltd. Bifendate Tablets Product Portfolios and Specifications

    • 13.2.3 Pyeong Kwang Pharmaceutical Co., Ltd. Bifendate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 Pyeong Kwang Pharmaceutical Co., Ltd. Main Business Overview

    • 13.2.5 Pyeong Kwang Pharmaceutical Co., Ltd. Latest Developments

  • 13.3 Chifeng Weikang Biochemical Pharmaceutical Co., Ltd.

    • 13.3.1 Chifeng Weikang Biochemical Pharmaceutical Co., Ltd. Company Information

    • 13.3.2 Chifeng Weikang Biochemical Pharmaceutical Co., Ltd. Bifendate Tablets Product Portfolios and Specifications

    • 13.3.3 Chifeng Weikang Biochemical Pharmaceutical Co., Ltd. Bifendate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 Chifeng Weikang Biochemical Pharmaceutical Co., Ltd. Main Business Overview

    • 13.3.5 Chifeng Weikang Biochemical Pharmaceutical Co., Ltd. Latest Developments

  • 13.4 Shanghai Jinbu Huan Lankao Pharmaceutical Co., Ltd.

    • 13.4.1 Shanghai Jinbu Huan Lankao Pharmaceutical Co., Ltd. Company Information

    • 13.4.2 Shanghai Jinbu Huan Lankao Pharmaceutical Co., Ltd. Bifendate Tablets Product Portfolios and Specifications

    • 13.4.3 Shanghai Jinbu Huan Lankao Pharmaceutical Co., Ltd. Bifendate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 Shanghai Jinbu Huan Lankao Pharmaceutical Co., Ltd. Main Business Overview

    • 13.4.5 Shanghai Jinbu Huan Lankao Pharmaceutical Co., Ltd. Latest Developments

  • 13.5 Jiangsu Pengyao Pharmaceutical Co., Ltd.

    • 13.5.1 Jiangsu Pengyao Pharmaceutical Co., Ltd. Company Information

    • 13.5.2 Jiangsu Pengyao Pharmaceutical Co., Ltd. Bifendate Tablets Product Portfolios and Specifications

    • 13.5.3 Jiangsu Pengyao Pharmaceutical Co., Ltd. Bifendate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 Jiangsu Pengyao Pharmaceutical Co., Ltd. Main Business Overview

    • 13.5.5 Jiangsu Pengyao Pharmaceutical Co., Ltd. Latest Developments

  • 13.6 Shanxi Taiyuan Pharmaceutical Co., Ltd.

    • 13.6.1 Shanxi Taiyuan Pharmaceutical Co., Ltd. Company Information

    • 13.6.2 Shanxi Taiyuan Pharmaceutical Co., Ltd. Bifendate Tablets Product Portfolios and Specifications

    • 13.6.3 Shanxi Taiyuan Pharmaceutical Co., Ltd. Bifendate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 Shanxi Taiyuan Pharmaceutical Co., Ltd. Main Business Overview

    • 13.6.5 Shanxi Taiyuan Pharmaceutical Co., Ltd. Latest Developments

  • 13.7 Liaoyuan Baikang Pharmaceutical Co., Ltd.

    • 13.7.1 Liaoyuan Baikang Pharmaceutical Co., Ltd. Company Information

    • 13.7.2 Liaoyuan Baikang Pharmaceutical Co., Ltd. Bifendate Tablets Product Portfolios and Specifications

    • 13.7.3 Liaoyuan Baikang Pharmaceutical Co., Ltd. Bifendate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 Liaoyuan Baikang Pharmaceutical Co., Ltd. Main Business Overview

    • 13.7.5 Liaoyuan Baikang Pharmaceutical Co., Ltd. Latest Developments

  • 13.8 Liaoning Yaolian Pharmaceutical Co., Ltd.

    • 13.8.1 Liaoning Yaolian Pharmaceutical Co., Ltd. Company Information

    • 13.8.2 Liaoning Yaolian Pharmaceutical Co., Ltd. Bifendate Tablets Product Portfolios and Specifications

    • 13.8.3 Liaoning Yaolian Pharmaceutical Co., Ltd. Bifendate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.8.4 Liaoning Yaolian Pharmaceutical Co., Ltd. Main Business Overview

    • 13.8.5 Liaoning Yaolian Pharmaceutical Co., Ltd. Latest Developments

  • 13.9 Ruiyang Pharmaceutical Co., Ltd.

    • 13.9.1 Ruiyang Pharmaceutical Co., Ltd. Company Information

    • 13.9.2 Ruiyang Pharmaceutical Co., Ltd. Bifendate Tablets Product Portfolios and Specifications

    • 13.9.3 Ruiyang Pharmaceutical Co., Ltd. Bifendate Tablets Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.9.4 Ruiyang Pharmaceutical Co., Ltd. Main Business Overview

    • 13.9.5 Ruiyang Pharmaceutical Co., Ltd. Latest Developments

• 14 Research Findings and Conclusion